Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biotricity Inc
(NQ:
BTCY
)
0.8997
-0.0273 (-2.94%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Biotricity Inc
< Previous
1
2
3
4
Next >
Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock
September 13, 2021
Underwritten Public Offering of Common Stock Resulted in Total Gross Proceeds of $16 Million REDWOOD CITY, CA / ACCESSWIRE / September 13, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference
September 08, 2021
Company's Momentum Continuing with Sales Growth, Recent Nasdaq listing and Successful Equity Raise REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Completes Nasdaq Listing
August 30, 2021
Closes $15 Million Underwritten Public Offering REDWOOD CITY, CA / ACCESSWIRE / August 30, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market
August 26, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 26, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the pricing of an underwritten public...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Announces Proposed Underwritten Public Offering of Common Stock in Connection with Expected Nasdaq Listing
August 25, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 25, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it intends to offer shares of its...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter
August 16, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide financial results for its fiscal...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021
August 12, 2021
REDWOOD CITY, CA / ACCESSWIRE / August 12, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity's 2021 Fiscal Fourth Quarter Growth Trend Continues into Fiscal 2022
July 07, 2021
Fiscal Q1-22 to be the 9th quarter of growth and biggest quarter to date REDWOOD CITY, CA / ACCESSWIRE / July 7, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Reports Record Quarterly and Annual Revenue for Fiscal 2021
June 15, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 15, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, is pleased to provide unaudited, preliminary financial...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Report Fourth Quarter Fiscal 2021 and Financial Results on June 15, 2021
June 09, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 9, 2021 / Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will release its financial results...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Present at 2021 LD Micro Invitational XI
June 01, 2021
REDWOOD CITY, CA / ACCESSWIRE / June 1, 2021 / Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that its...
From
Biotricity, Inc.
Via
AccessWire
Biotricity Announces 2021 Uplisting Strategy to Major Exchange
May 25, 2021
REDWOOD CITY, CA / ACCESSWIRE / May 25, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Present its Disruptive Medical Technologies at the Benzinga Global Small Cap Conference on May 14
May 14, 2021
Presentation to focus on flagship Bioflux® product for the multi-billion cardiac monitoring and diagnostic market REDWOOD CITY, CA / ACCESSWIRE / May 14, 2021 /Biotricity, Inc. (OTCQB:BTCY)...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity Selected as Finalist in Fast Company's 2021 World Changing Ideas Awards
May 04, 2021
REDWOOD CITY, CA / ACCESSWIRE / May 4, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce that...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Biotricity to Report Record Revenue Results for Fiscal 2021
April 14, 2021
Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April 14, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and...
From
Biotricity, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.